Analysis of data from a large, multistate outbreak of fungal infections showed substantial morbidity and mortality. The infections were associated with injection of a contaminated glucocorticoid medication from a single compounding pharmacy. Rapid public health actions included prompt recall of the implicated product, notification of exposed persons, and early outreach to clinicians.
Background:In March 2017, the New Jersey Department of Health received reports of 3 patients who developed septic arthritis after receiving intra-articular injections for osteoarthritis knee pain at the same private outpatient facility in New Jersey. The risk of septic arthritis resulting from intra-articular injection is low. However, outbreaks of septic arthritis associated with unsafe injection practices in outpatient settings have been reported.Methods:An infection prevention assessment of the implicated facility’s practices was conducted because of the ongoing risk to public health. The assessment included an environmental inspection of the facility, staff interviews, infection prevention practice observations, and a medical record and office document review. A call for cases was disseminated to healthcare providers in New Jersey to identify patients treated at the facility who developed septic arthritis after receiving intra-articular injections.Results:We identified 41 patients with septic arthritis associated with intra-articular injections. Cultures of synovial fluid or tissue from 15 of these 41 case patients (37%) recovered bacteria consistent with oral flora. The infection prevention assessment of facility practices identified multiple breaches of recommended infection prevention practices, including inadequate hand hygiene, unsafe injection practices, and poor cleaning and disinfection practices. No additional cases were identified after infection prevention recommendations were implemented by the facility.Discussion:Aseptic technique is imperative when handling, preparing, and administering injectable medications to prevent microbial contamination.Conclusions:This investigation highlights the importance of adhering to infection prevention recommendations. All healthcare personnel who prepare, handle, and administer injectable medications should be trained in infection prevention and safe injection practices.
Objective: Medical notes provide a rich source of information that can be used as additional supporting information for healthcare-associated infection (HAI) investigations. The medical notes from 10 New Jersey (NJ) emergency departments (ED) were searched to identify cases of surgical-site infections (SSI).Introduction: EpiCenter, NJ’s statewide syndromic surveillance system, collects ED registration data. The system uses chief complaint data to classify ED visits into syndrome categories and provides alerts to state and local health departments for surveillance anomalies.After the 2014 Ebola outbreak in West Africa, the New Jersey Department of Health (NJDOH) started collecting medical notes including triage notes, which contain more specific ED visit information than chief complaint, from 10 EDs to strengthen HAI syndromic surveillance efforts.In 2017, the NJDOH was aware of one NJ resident whose surgical site was infected following a cosmetic procedure outside of the US. This event triggered an intensive data mining using medical notes collected in EpiCenter. The NJDOH staff searched one week of medical notes data in EpiCenter with a specific keyword to identify additional potential cases of surgical-site infections (SSI) that could be associated with medical tourism.Methods: The NJ resident whose surgical site was infected following a cosmetic procedure outside of the US was interviewed by NJDOH staff for details about their procedure. First, the patient’s interview results were reviewed to prepare a set of SSI and travel related keywords to be used in performing data mining in medical notes collected in EpiCenter. The interviewed patient had tummy tuck and liposuction surgeries; therefore, it was decided to search for “tummy tuck” as a keyword in EpiCenter. The medical notes from August 31, 2017 through September 8, 2017 were reviewed to identify patients who developed SSI following a cosmetic procedure outside of the US.Results: The search yielded 8 ED visits, one of which was identified as possible surgical site infection. The medical notes details indicated that the ED patient, a 21-year old female who had abdominoplasty (tummy tuck) and liposuction surgeries about a month prior, presented with post-surgical complaints such as pain, surgical dehiscence, and purulent drainage at the surgery site. Chief complaint text for the same ED patient indicated the patient had headache and dizziness which were less specific than medical notes.The NJDOH staff contacted the ED to obtain additional information regarding the infection. The lab results from the ED showed that the patient was identified as having a post-surgery infection, which prompted public health to follow-up whether it was an HAI.Conclusions: The limitation for this project was that the keyword search was conducted only on one week of data. The timeframe was kept short to pilot testing the keyword identified. The Centers for Disease Control and Prevention suggests clinicians should consider nontuberculous mycobacteria (NTM) infections in the differential diagnosis for all people who have wound infections after surgery abroad, including surgery that has occurred weeks to months previously (1). Future studies will explore larger data sets with additional keywords (e.g. country and organism) to see if potential cases can be identified as possible HAI and/or outbreak that will lead to public health investigations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.